+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American Tissue Diagnostics Market 2019-2025

  • PDF Icon


  • March 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5013407
UP TO OFF until Dec 31st 2022
North American Tissue Diagnostics Market Size, Share & Trends Analysis Report by Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology And Workflow Management, Special Staining and Hematoxylin & Eosin (H&E) Stain) By Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer and Non-small Cell Lung Carcinoma) By Product (Instruments and Consumables) By End-user (Hospitals, Pharmaceuticals, Research Institute, Laboratories, and Other Research) Forecast period 2019-2025.

The North American tissue diagnostics market is anticipated to grow at a CAGR 6.6% during the forecast period. The most widely adopted tissue diagnostic segment in North America includes Immunohistochemistry (IHC), in situ hybridization (ISH), special staining and digital pathology. The rise in incidence and prevalence rate of cancer diseases is another key factor boosting the growth of the North American tissue diagnostics market. Tissue diagnostics market by diagnoses such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small-cell lung cancer (NSCLC) among others are in huge demand due to the rise in Cancer and related diseases in North America.

North American is expected to contribute significantly to the growth of the tissue diagnostics market due to various driving factors which include growth of diagnostic segments, rise in adoption of personalized medicine, robust investment in research & development in North American tissue diagnostic market.

Research and development is the key strategy adopted by the market players contributing to the growth of tissue diagnostics through innovative strategies such as the adoption of robotic automation in diagnostic centers. Major players that are active in the market that includes Abbott Laboratories, Inc., Agilent Technologies, Biogenex Laboratories, Cell Signaling Technology, Inc., Bio SB, Danaher Corporation, Life Technologies, Thermo Fisher Scientific, Inc, Sigma-Aldrich, and so forth are based in North America and contributing in the growth of tissue diagnostics market.

Research Methodology

The market study of the North American Tissue Diagnostics market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for the Healthcare industry, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Tissue Diagnostics Market Research and Analysis by Technology
2. North American Tissue Diagnostics Market Research and Analysis by Product
3. North American Tissue Diagnostics Market Research and Analysis by Diseases
4. North American Tissue Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the North American Tissue Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American Tissue Diagnostics market.
  • Insights about market determinants which are stimulating the North American Tissue Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.1. Opportunities
5. Market Segmentation
5.1. North American Tissue Diagnostics Market by Technology
5.1.1. Immunohistochemistry
5.1.2. In Situ Hybridization
5.1.3. Digital Pathology And Workflow Management
5.1.4. Special Staining
5.1.5. Hematoxylin & Eosin (H&E) Stain
5.2. North American Tissue Diagnostics Market by Diseases
5.2.1. Breast Cancer
5.2.2. Gastric Cancer
5.2.3. Lymphoma
5.2.4. Prostate Cancer
5.2.5. Non-small Cell Lung Carcinoma
5.3. North America Tissue Diagnostics Market by Product
5.3.1. Instruments
5.3.2. Consumables
5.4. North America Tissue Diagnostics Market by End-User
5.4.1. Hospitals
5.4.2. Pharmaceuticals
5.4.3. Research Institute
5.4.4. Laboratories
5.4.5. Other Research
6. Regional Analysis
6.1. North American
6.1.1 United States
6.1.2 Canada

7 Company Profiles
7.1 Alere, Inc.
7.2 Becton, Dickinson and Co.,
7.3 Bio SB
7.4 Biogenex Laboratories
7.5 BioMérieux SA
7.6 Cell Signalling Technology, INC.
7.7 DiaGenic ASA
7.8 Prometheus Laboratories
7.10 Stryker Corp.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Alere, Inc.
  • Becton, Dickinson and Co.,
  • Bio SB
  • Biogenex Laboratories
  • BioMérieux SA
  • Cell Signalling Technology, INC.
  • DiaGenic ASA
  • Prometheus Laboratories
  • Stryker Corp.